[FOR RELEASE May 6, 2014 China Biologic Reports Financial Results for the First Quarter of 2014 1Q14 Total Sales Increase 4.1% to $56.3Million 1Q14 Operating Margin Increases to 49.7% from 1Q14 Non-GAAP Net Income Increases 16.3% to $ 19.1Million BEIJING, China – May 6, 2014 – First Quarter 2014 Financial Highlights · Total sales · Gross profit · Income from] []

[] [Consent of Independent Registered Public Accounting Firm The Board of Directors China Biologic Products, Inc.: We consent to the incorporation by reference in registration statements (No. 333-171069 and 333-182624) on Form S-3 and the registration statement (No. 333-151263) on Form S-8 of China Biologic Products, Inc. of our reports dated March 12, 2014, with respect to the consolidated balance sheets] [CERTIFICATIONS I, David (Xiaoying) Gao, certify that: 1. I have reviewed this annual report on Form 10-K of China Biologic Products, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such] [CERTIFICATIONS I, Ming Yang, certify that: 1. I have reviewed this annual report on Form 10-K of China Biologic Products, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements] [OF THE SARBANES-OXLEY ACT OF 2002 2. Information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company. th 12 David (Xiaoying) Gao Chief Executive Officer] [OF THE SARBANES-OXLEY ACT OF 2002 2. Information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company. th 12 Ming Yang Chief Financial Officer (Principal Financial and Accounting Officer)]